|Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions|
RS McIntyre, DS Cha, JK Soczynska, HO Woldeyohannes, LA Gallaugher, ...
Depression and anxiety 30 (6), 515-527, 2013
|Inflamed moods: a review of the interactions between inflammation and mood disorders|
JD Rosenblat, DS Cha, RB Mansur, RS McIntyre
Progress in Neuro-Psychopharmacology and Biological Psychiatry 53, 23-34, 2014
|Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach|
RS McIntyre, MJ Filteau, L Martin, S Patry, A Carvalho, DS Cha, M Barakat, ...
Journal of affective disorders 156, 1-7, 2014
|The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project|
RS McIntyre, JZ Soczynska, HO Woldeyohannes, MT Alsuwaidan, ...
Comprehensive psychiatry 56, 279-282, 2015
|Potential roles of zinc in the pathophysiology and treatment of major depressive disorder|
W Swardfager, N Herrmann, RS McIntyre, G Mazereeuw, K Goldberger, ...
Neuroscience & biobehavioral reviews 37 (5), 911-929, 2013
|The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder|
RS McIntyre, HX Xiao, K Syeda, M Vinberg, AF Carvalho, RB Mansur, ...
CNS drugs 29 (7), 577-589, 2015
|The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the …|
RS McIntyre, JK Soczynska, DS Cha, HO Woldeyohannes, RS Dale, ...
Journal of affective disorders 172, 259-264, 2015
|Cannabidiol in medical marijuana: research vistas and potential opportunities|
C Rong, Y Lee, NE Carmona, DS Cha, RM Ragguett, JD Rosenblat, ...
Pharmacological Research 121, 213-218, 2017
|Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study|
RB Mansur, J Ahmed, DS Cha, HO Woldeyohannes, M Subramaniapillai, ...
Journal of affective disorders 207, 114-120, 2017
|Predominant polarity as a course specifier for bipolar disorder: a systematic review|
AF Carvalho, RS McIntyre, D Dimelis, X Gonda, M Berk, PR Nunes-Neto, ...
Journal of affective disorders 163, 56-64, 2014
|Treatment-emergent adverse events associated with atypical antipsychotics|
DS Cha, RS McIntyre
Expert opinion on pharmacotherapy 13 (11), 1587-1598, 2012
|Gut emotions-mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders|
A Slyepchenko, A F Carvalho, D S Cha, S Kasper, R S McIntyre
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
|The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project|
RS McIntyre, JK Soczynska, SS Liauw, HO Woldeyohannes, E Brietzke, ...
The International Journal of Psychiatry in Medicine 43 (2), 165-177, 2012
|Advancing biomarker research: utilizing ‘Big Data’approaches for the characterization and prevention of bipolar disorder|
RS McIntyre, DS Cha, JM Jerrell, W Swardfager, RD Kim, LG Costa, ...
Bipolar disorders 16 (5), 531-547, 2014
|Crosstalk between metabolic and neuropsychiatric disorders|
O Kaidanovich-Beilin, DS Cha, RS McIntyre
F1000 biology reports 4, 2012
|The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder|
RS McIntyre, MW Best, CR Bowie, NE Carmona, DS Cha, Y Lee, ...
The Journal of clinical psychiatry 78 (7), 873-881, 2017
|A new perspective on the anti-suicide effects with ketamine treatment: a procognitive effect|
Y Lee, K Syeda, NA Maruschak, DS Cha, RB Mansur, IK Wium-Andersen, ...
Journal of clinical psychopharmacology 36 (1), 50-56, 2016
|A review of FDA-approved treatment options in bipolar depression|
RS McIntyre, DS Cha, RD Kim, RB Mansur
CNS spectrums 18 (s1), 1-21, 2013
|Nitric oxide and major depressive disorder: pathophysiology and treatment implications|
P Kudlow, DS Cha, AF Carvalho, RS McIntyre
Current molecular medicine 16 (2), 206-215, 2016
|Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder|
PA Kudlow, DS Cha, RW Lam, RS McIntyre
Sleep medicine 14 (10), 943-949, 2013